Dendritic cells (DCs) are phagocytic cells of hematopoietic origin located strategically for antigen (Ag) sampling in tissues such as the mucosae that interface with the external environment. 1 Upon Ag recognition, DCs are activated and migrate to the lymph nodes, where they present Ag-derived peptides to naive T lymphocytes and induce an effective immune response. The number of DCs circulating in the blood is extremely low; DCs are thus commonly generated in vitro by differentiation from monocyte precursors. 2 Since DCs can be manipulated ex vivo, numerous efforts have been undertaken for exploiting them in the development of antitumor and antiviral therapies. [3] [4] [5] Genomic approaches have been used to characterize DCs in more molecular terms. A series of genes have been identified, some DC specific, that encode lectin or lectinlike receptors. Many of these lectins are members of the calcium-dependent C-type lectin receptor (CLR) family and operate as constituents of the powerful Ag capture and uptake mechanism of DCs. 6 Membrane-bound CLRs bind pathogens, which are then subjected to intracellular degradation and subsequent antigen loading of presenting MHC molecules responsible for the activation of T cells. 7 Dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN; CD209) is a CLR initially described as an ICAM-3 (intercellular adhesion molecule-3) binding protein mediating DC-T cell interactions 8 as well as a major HIV-1 receptor on DCs. 9 DC-SIGN is responsible for the binding and uptake of several other pathogens, such as Ebola virus, 10 hepatitis C virus (HCV), 11 Candida albicans, 12 and Mycobacterium tuberculosis. 13 The interactions with these microorganisms occur upon recognition of a specific pathogen-associated carbohydrate moiety by DC-SIGN, either branched mannose structures (mannan) or fucose moieties (LewisX). 14 Ag uptake via DC-SIGN leads to Ag processing and presentation. 7, 15 However, pathogens such as HIV-1, HCV, and M. tuberculosis escape lysosomal degradation, thereby avoiding host immune surveillance. 9, 11, 13, 16 Despite the central role of DC-SIGN-mediated Ag uptake in DC function, little is known about the underlying molecular mechanism(s) of the initial entry and subsequent sorting pathways. Since neither the kinetics nor the uptake of ligands via DC-SIGN had been directly visualized, we undertook a study of the binding and internalization of "virussized" particles conjugated to carbohydrates or viral coat proteins. For this purpose, biotinylated ligands of DC-SIGN, such as LewisX or the HIV-1 envelope protein gp120, were bound to commercially available PEG-coated fluorescent quantum dots (QDs) bioconjugated with streptavidin. 17 After conjugation, the diameter of the QDs was ∼40 nm, comparable to the size of some viruses such as HCV. 18, 19 Due to their resistance to metabolic degradation as well as their exceptional photostability, 17, 20 the binding and intracellular behavior of QDs conjugated to receptor ligands can be monitored over long periods of time as shown in our laboratory in studies of the EGF receptor. 21, 22 Here we report the delineation of the DC-SIGN-mediated endocytosis mechanism in a similar fashion.
Ligand-Coated QDs Bind to DC-SIGN and Are Internalized. To investigate the intracellular routing of antigen internalization, we preloaded streptavidin QDs with biotinylated polymeric LewisX (pLeX-QDs), the HIV-1 envelope glycoprotein gp120 (gp120-QDs), or the anti-DC-SIGN mAb AZN-D1 (D1-QDs) (Supporting Information Table 1 ). The specificity of binding was demonstrated by binding to CHO cells that express human DC-SIGN (CHO-DC-SIGN). Confocal microscopy imaging demonstrated that all DC-SIGN ligands conjugated to QDs were able to interact with and be internalized by DC-SIGN (Figure 1a-c) . Unlike pLeX, monomeric LewisX (mLeX) is not recognized by DC-SIGN. 23 Accordingly, mLeX-QDs did not bind to the cells (Figure 1d ). Furthermore, a clear inhibition was exerted by the carbohydrate mannan on the interaction between CHO-DC-SIGN and gp120-QDs (Figure 1e ). Similar mannanmediated inhibition was observed when pLeX-QDs or D1-QDs were used (data not shown).
We quantified both ligand binding and internalization of the specific ligand-QD complexes. Figure 2a shows a time course of live CHO-DC-SIGN cells incubated with pLeXQDs. Image segmentation processing was applied to define the membrane-associated-and the internalized-QD fraction (Figure 2b inset) . For quantitation, CHO-DC-SIGN cells were cotransfected with the cell surface receptor erbB1-EGFP (localized at the cell surface only) to delineate the plasma membrane during image segmentation. The presence of erbB1-EGFP did not alter the specific binding of ligandcoated QDs to DC-SIGN ( Figure S1 ).
The kinetics of accumulation of pLeX-QDs at the cell surface and in the cytoplasm is shown in Figure 2b . Significant cell surface binding was visualized after 5-10 min, whereas internalization was detected only after 10-15 min postaddition of QDs. Moreover, while the endocytosis followed a linear course, surface binding was more rapid and reached a plateau after 30 min. Notably, no colocalization between internalized QDs and erbB1-EGFP was detected, indicating the absence of unspecific interactions between this receptor and the DC-SIGN-specific ligand-conjugated QDs. Similar results were obtained with gp120-QDs.
We compared these data with the binding and internalization of ligand-conjugated QDs by a DC-SIGN mutant, DC-SIGN-∆Repeat ( Figure S2a) , which lacks the extracellular neck domain thought to be responsible for tetramerization and is unable to bind to virus particles. 24 The interaction of live CHO-DC-SIGN-∆Repeat cells with pLeX-QDs was imaged under the same conditions described above for wildtype DC-SIGN (Figure 2b ). Whereas binding and internalization of pLeX-QDs by wild-type DC-SIGN could be monitored for longer than 30 min, the ∆Repeat mutant showed neither detectable binding nor internalization over the same period of time ( Figure 2b and Figure S2b ). Similar results were obtained when gp120-QDs were used with DC-SIGN-∆Repeat expressing cells (data not shown). The expression levels of DC-SIGN wild-type and ∆Repeat were comparable; thus, the difference in binding was not due to a smaller amount of the mutated DC-SIGN at the cell surface (data not shown).
We previously demonstrated that DC-SIGN can reside in cholesterol-enriched lipid rafts and that its binding properties are affected by perturbation of lipid microdomains (rafts). 25 Disruption of lipid rafts by adding the cholesterol extracting agent methyl--cyclodextrin (MCD) to CHO-DC-SIGN cells significantly decreased the binding rate and greatly inhibited the internalization of pLeX-QDs ( Figure 2b and Figure S2c ). Moreover, even after 60 min of incubation with the QDs, only a weak binding was observed at the plasma membrane of the treated cells and there was no internalization ( Figure S2d ). These results demonstrate that only QDs conjugated to specific ligands are recognized and internalized by DC-SIGN and that the oligomerization state of DC-SIGN as well as membrane raft integrity greatly influenced the interaction with these fluorescent, virus-sized particles.
Time-Dependent Colocalization of Internalized QDs with Different Cellular Compartments. We used gp120-QDs to elucidate the entry steps of DC-SIGN-mediated We quantified the colocalization of the internalized QDs with DC-SIGN, clathrin, or caveolin-1 by calculating the correlation coefficient C (see methods) in multiple images. As shown in Figure 3g , only DC-SIGN and clathrin showed a significant colocalization at early time points, which was lost after prolonged incubation. Further support for the notion that DC-SIGN-mediated endocytosis of gp120-QDs is clathrin-dependent was provided by the colocalization of internalized gp120-QDs with mRFP-Rab5 in CHO-DC-SIGN cells (Figure 3h ). Rab5 is present in vesicles that have just shed their clathrin coats and are entering the early endosomal compartment. 26 Internalized QDs never colocalized with the Golgi apparatus, as shown by labeling with the Golgi marker SulfoT-EGFP (Figure 3i ). Similar results were obtained with pLeX-QD (data not shown). These data clearly demonstrate that DC-SIGN-mediated endocytosis of virus-sized particles occurs via a clathrin-dependent, caveolin-independent pathway.
Dendritic Cells Bind and Internalize Ligand-Coated QDs. Although DC-SIGN expressed in CHO cells served in this paper and previous work 27 as a valid model system for studying the CLR, these cells do not recapitulate the full repertoire of activities of native DCs. Thus, we performed similar experiments with ligand-conjugated QDs on DCs. Binding of gp120-QDs to fresh human DCs was detectable 10 min after addition of the QDs (Figure 4a ) and internalization increased thereafter. Prior incubation of DCs with the blocking anti-DC-SIGN mAb AZN-D1 specifically prevented binding of the gp120-QDs to DCs (Figure 4b ). Moreover, no unspecific binding was observed upon addition of ligandunconjugated streptavidin-QDs (data not shown). Figure 4c shows a reconstructed three-dimensional image of DCs that had internalized many gp120-QDs during 30 min of incubation. Subsequent to fixation, DC-SIGN was labeled extracellularly with a mAb in order to define the cell membrane. Interestingly, most of the endocytosed QDs accumulated at the center of the cell, although a large fraction was still visible in smaller structures underneath the cell membrane. The orthogonal sections of another DC (Figure 4d ) further support the conclusion that the DCs internalized the ligandconjugated QDs.
GP120-QDs Reach the Antigen Processing and Loading Compartment. To further investigate the intracellular destiny of the internalized QDs on DCs, we labeled several molecules potentially involved in the endocytic pathway. Similarly to CHO-DC-SIGN cells, DCs also internalized (Figure 5a ) and via CCP (Figure 5b) . No colocalization between QDs and caveolin or the integrin LFA-1 was observed ( Figure S3 ). In addition, we determined that at incubation times longer than 30 min the QD accumulated in the lysosomal compartment, as shown by the strong colocalization of the internalized QD with the lysosomal marker LAMP-1 (Figure 5c ). Moreover, under the same conditions, an anti-gp120 mAb revealed that the coated ligand (i.e., gp120) completely colocalized with the QDs both in early endosomes and in lysosomes (Figure 5d ). The specificity of this labeling was confirmed by the absence of gp120 signal in the neighboring DCs that had not internalized the QDs.
GP120-QDs via DC-SIGN-enriched vesicles
Finally, we investigated whether the internalized QDs could be detected inside the DC after prolonged incubations. The DCs were exposed to gp120-QDs for 1 h at 37°C. After the excess of unbound QDs was washed away, the cells were kept in culture in normal medium for 48 h and imaged. The cargo of intracellular QDs ( Figure S4 ) was clearly evident and was demonstrated to be colocalized with the MHCII enriched compartment, identified with a marker for HLA-DR (Figure 5e ).
Discussion. We previously reported the application of photostable QDs to study signal transduction. 21, 22 Here, we made use of ligand-conjugated QDs for visualizing the binding and internalization of antigens mediated by DC-SIGN in living cells. We demonstrated that DC-SIGN internalizes virus-sized ligand-conjugated QDs via a clathrindependent mechanism. Colocalization of the internalized QDs with DC-SIGN and clathrin was lost 10 min after internalization, and at times longer than 30 min postbinding, the QDs, as well as the conjugated ligand, accumulated in the lysosomal compartment. Finally, we showed that internalized QDs could be detected inside living cells even after prolonged (up to 48 h) incubations and strongly colocalized with MHCII-enriched compartments. These results suggest that internalization of Ags conjugated to QDs alters neither cell viability nor the proper Ag degradation inside lysosomes and subsequent loading of MHCII molecules. Thus, the QDs provide a new, sensitive, and convenient method for following antigen-loaded cells as discussed below.
The binding of the ligand-conjugated QDs to the cell surface could be visualized after 5-10 min, reaching a plateau after 30 min, whereas the endocytosis followed a linear course subsequent to binding (Figure 2) . We conclude that the cellular endocytotic machinery is the rate-limiting process for the internalization of ligand-conjugated QDs via DC-SIGN.
Previous studies from one of our laboratories revealed that the organization of DC-SIGN in discrete nanoclusters at the DC plasma membrane is essential for binding and uptake of virus particles and that both clustered and randomly distributed DC-SIGN molecules bind to micrometer-sized particles as well as soluble ligands. 25 Here, we extend these findings and demonstrate that the mutant DC-SIGN-∆Repeat, defective in forming tetramers and of binding to HIV-1, 24 does not bind or internalize ligand-conjugated QDs (Figure 2b and Figure S2 ). These observations confirm a similarity in size and antigenicity of the ligand-conjugated QDs used in our experiments compared with virus particles as well as the absence of large cross-linked QD aggregates.
Using complementary techniques, we and others showed that DC-SIGN may reside within lipid rafts, 25 ,28 a finding consistent with the inhibition of QD-ligand binding and internalization of cholesterol-depleted CHO-DC-SIGN cells (Figure 2 and Figure S2 ). In the case of both CHO-DC-SIGN and DCs, QD-ligands internalized through DC-SIGN colocalize with CCPs (Figure 3 and 5) . CCPs and lipid rafts are considered to be mutually exclusive compartments of the plasma membrane. 29 However, cholesterol extraction has been also reported to affect CCP formation. 30 Although a dileucine motif, which is presumed to mediate the interaction with CCPs, 31 has been identified in the cytoplasmic tail of DC-SIGN, 7 direct evidence for an interaction between DC-SIGN and clathrin has been lacking so far. Our study provides the first clear demonstration that the internalization of DC-SIGN antigens occurs via a clathrin-dependent, caveolin-independent mechanism (Figures 3a-g and 5b) . Conceivably, ligand binding induces DC-SIGN to exit lipid rafts and redistribute with its bound antigen toward CCPs ( Figure 6) . A raft-dependent, clathrin-independent mechanism may also play a role in DC-SIGN-mediated endocytosis ( Figure 6 ). These possibilities are presently under investigation.
We quantified the colocalization between internalized ligand-conjugated QDs and DC-SIGN-or clathrin-enriched vesicles at different time points (Figure 3) . Interestingly, 10 min after internalization the endocytosed QDs seemed to segregate from DC-SIGN, suggesting that the ligand and receptor followed different internalization routes. Whether DC-SIGN recycles back to the surface or is quickly degraded in the lysosomes is still unknown. The application of Agconjugated QDs in combination with compounds interfering with either exo-or endocytosis will hopefully provide additional information in this regard.
Direct in vivo visualization of cellular macromolecules has been successfully achieved in many systems by the introduction of transgenes expressing visible fluorescent protein fusions. We prepared and transfected a construct of GFP fused to the intracellular N-terminus of DC-SIGN into different cell lines (data not shown). This fusion protein, while capable of binding to micrometer-sized ligand-coated particles, 32 did not bind to ligand-conjugated QDs as efficiently as the wild-type DC-SIGN ( Figure S5 ). We analyzed CHO-DC-SIGN-GFP expressing cells by energy migration Förster resonance energy transfer (emFRET or homotransfer FRET) measured in the confocal laser-scanning microscope. 33 We found that the DC-SIGN-GFP on the cell surface was primarily present as a dimer (Lidke et al., unpublished data) . Since protein tetramerization is required in order for DC-SIGN to bind multivalent carbohydrates, 34 we conclude that the presence of GFP interferes with the formation of a proper quaternary structure, thereby hampering the virus binding capacity.
Standard techniques for transfecting DNA constructs into primary DCs are highly inefficient, thus limiting the application of visible fluorescent protein (VFP)-based constructs to study DC-specific receptors directly within their physiological context. Quantitative approaches based on multiple combinations of QDs and ligands provide an alternative means for simultaneously tracking the internalization of 3 Antigencoupled QDs ingested by DCs are a potential tool for determining the location and duration of therapeutic DCs. In this study we determined that internalized QDs, still bearing the ligand, colocalized with the LAMP-1-enriched compartment, showing that the ligand-conjugated QDs are not retained in vesicles of the early sorting pathways but are instead able to reach the lysosomes (Figure 5c,d) . Moreover, the fluorescent signal of endocytosed QDs in DCs was still detectable for at least 2 days after internalization and colocalized with the MHCII loading compartment (Figure 5e and Figure S4 ). Being nontoxic, metabolically resistant, and highly photostable, QDs could serve to monitor antigen-loaded DC within tissues after readministration to animals.
Compared to exogenous peptide loading, a more direct and less laborious strategy for improving vaccine efficiency would be to target Ags to DCs in vivo via specific cell surface receptors. Recently, several studies conducted on antigen targeting to CLRs for vaccination purposes indicated that CLRs are potential Ag targeting receptors. 4, 35, 36 In fact, antibody-mediated targeting of Ag to DCs via DC-SIGN effectively induced Ag-specific naive as well as recall T-cell responses. 15 On the other hand, DC-SIGN is targeted by pathogens like M. tuberculosis, HIV-1, and HCV, thereby avoiding degradation in lytic compartments. 11, 13, 16 Although ligand-conjugated QDs do not exactly reproduce the immune escape of viruses, they constitute very useful tools for mimicking viral binding and entry. The more detailed information thereby gained on how different Ags are internalized via DC-SIGN and other CLRs will be instrumental for the rationale design of efficient CLR-based therapeutic strategies.
The broad range of QD colors and sizes allows simultaneous tracking of DCs loaded with different antigens or even different DC subsets. The recent advances in the chemistry of QD coating permit the simultaneous conjugation of two or more different molecules, and thus, the simultaneous stimulation of several receptors, 37 further broadening the application potential of these fluorescent probes for dynamic studies of cellular processes. 
